Permissibility of prenatal diagnosis and abortion for fetuses with severe genetic disorder: Type 1 spinal muscular atrophy

Annals of Saudi Medicine

Volumn 30, Issue 6, 2010, Pages 427-431

  Sasongko, Teguh H ^a   Salmi, Abd Razak ^b   Zilfalil, Bin Alwi ^a   Albar, Mohammed Ali ^c   Mohd Hussin, Zabidi Azhar ^b  

^a Human Genome Center   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^c International Medical Center   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

FETUS DISEASE; GENETIC DISORDER; HUMAN; MEDICAL ABORTION; MEDICAL PRACTICE; MOSLEM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SPINAL MUSCULAR ATROPHY; TYPE 1 SPINAL MUSCULAR ATROPHY;

ABORTION, LEGAL; FEMALE; FETAL DISEASES; GENETIC TESTING; HUMANS; ISLAM; PREGNANCY; PRENATAL DIAGNOSIS; SEVERITY OF ILLNESS INDEX; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD;

EID: 78649343916     PISSN: 02564947     EISSN: 09754466     Source Type: Journal    
DOI: 10.4103/0256-4947.72259     Document Type: Review

References (28)

1. The 12th session of the Muslim World League Conference of Jurists, Mecca 10-17 February 1990, Islamic ruling regarding abortion for congenitally abnormal fetuses.
2. Albar MA. Policy and method of birth control (Arabic: Siyasat wa Wasayil Tahdid Annasl). Beirut: Al Aser Al Hadith Publication; 1991. p. 119-23.
3. Albar MA. Induced abortion from islamic perspective: Is it criminal or just elective? J Fam Community Med 2001;8:25-35.
4. Lunn MR, Wang CH. Spinal muscular atrophy. Lancet 2008;371:2120-33.
5. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-65
6. van der Steege G, Grootcholten PM, van der Vlies P, Draaijers TG, Osinga J, Cobben JM, et al. PCR-based DNA test to confirm clinical diagnosis of autosomal recessive spinal muscular atrophy. Lancet 1995;345:985-6.
7. Kesari A, Rennert H, Leonard DG, Phadke SR, Mittal B. Prenatal diagnosis of spinal muscular atrophy: Indian scenario. Prenat Diagn 2005;25:641-4.
8. Al-Jumah M, Majumdar R, Al-Rajeh S, Awada A, Chaves-Carbello E, Salih M, et al. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory proteins genes in Saudi patients with spinal muscular atrophy. Saudi Med J 2003;24:1052-4.
9. Mrad R, Dorboz I, Ben Jemaa L, Maazoul F, Trabelsi M, Chaabouni M, et al. Molecular analysis of the SMN1 and NAIP genes in 60 Tunisian spinal muscular atrophy patients. Tunis Med 2006;84:465-9.
10. Derakhshandeh-Peykar P, Esmaili M, Ousati-Ashtiani Z, Rahmani M, Babrzadeh F, Farshidi S, et al. Molecular analysis of the SMN1 and NAIP genes in Iranian patients with spinal muscular atrophy. Ann Acad Med Singapore 2007;36:937-41.
11. Watihayati MS, Zabidi-Hussin AM, Tang TH, Matsuo M, Nishio H, Zilfalil BA. Deletion analyses of SMN1 and NAIP genes in Malaysian spinal muscular atrophy patients. Pediatr Int 2007;49:11-4.
12. Savas S, Eraslan S, Kantarci S, Karaman B, Acarsoz D, Tukel T, et al. Prenatal prediction of childhood-onset spinal muscular atrophy (SMA) in Turkish families. Prenat Diagn 2002;22:703-9.
13. Dubowitz V. Very severe spinal muscular atrophy (SMA type 0): An expanding clinical phenotype. Eur J Paediatr Neurol 1999;3:49-51.
14. MacLeod MJ, Taylor JE, Lunt PW, Mathew CG, Robb SA. Prenatal onset spinal muscular atrophy. Eur J Paediatr Neurol 1999;3:65-72.
15. Bach JR. The use of mechanical ventilation is appropriate in children with genetically proven spinal muscluar atrophy type I: The motion for. Paediatr Respir Rev 2008;9:45-50.
16. Bach JR, Vega J, Majors J, Friedman A. Spinal muscular atrophy type I quality of life. Am J Phys Med Rehabil 2003;82:137-42.
17. Ryan MM. The use of invasive ventilation is appropriate in children with genetically proven spinal muscluar atrophy type I: The motion against. Paediatr Respir Rev 2008;9:51-4.
18. Wang CH, Carter TA, Das K, Xu J, Ross BM, Penchaszadeh GK, et al. Extensive DNA deletion associated with severe disease alleles on spinal muscular atrophy homologues. Ann Neurol 1997;42:41-9.
19. Feldkötter M, Schwarzer V, Wirth R, Wienker TF, Wirth B. Quantitative analyses of SMN1 and SMN2 based on realtime light-cycler PCR: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002;70:358-68.
20. Watihayati MS, Fatemeh H, Marini M, Atif AB, Zahiruddin WM, Sasongko TH, et al. Combination of SMN2 copy number and NAIP deletion predicts severity in spinal muscular atrophy. Brain Dev 2009;31:42-5.
21. Prior TW, Swoboda KJ, Scott HD, Hejmanowski AQ. Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2. Am J Med Genet 2004;130 A: 307-10.
22. Harada Y, Sutomo R, Sadewa AH, Akutsu T, Takeshima Y, Wada H, et al. Correlation between SMN2 copy number and clinical phenotype of spinal muscular atrophy: Three SMN2 copies fail to rescue some patients from the disease severity. J Neurol 2002;249:1211-9.
23. Tran VK, Sasongko TH, Hong DD, Hoan NT, Dung VC, Lee MJ, et al. SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy. Pediatr Int 2008;50:346-51.
24. Mailman MD, Heinz JW, Papp AC, Snyder PJ, Sedra MS, Wirth B, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002;4:20-6. (Pubitemid 44698460)
25. Migita M, Migita M, Uchikoba Y, Orimo H, Shimada T, Shimada T. Genetic diagnosis of Werdnig-Hoffman disease: A problem for application to prenatal diagnosis. J Nippon Med Sch 2003;70:45-8.
26. Abresch RT, Carter GT, Jensen M P, Kilmer DD. Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease. Am J Hosp Palliat Care 2002;19:39-48.
27. Chung BH, Wong VC, Ip P. Spinal muscular atrophy: Survival pattern and functional status. Pediatrics 2004;114: e548-53.
28. Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 1999;96:6307-11.